DB17802ExperimentalProtein Based Therapies
Docaravimab: Overview.
- Also known as
- Immunoglobulin g2, anti-(rabies virus strain evelyn-rockitniki-abelseth glycoprotein ectodomain epitope g-iii) (mus musculus monoclonal .gamma.2-chain), disulfide with mus musculus monoclonal .kappa.-chain, dimer · Immunoglobulin g2b-kappa, anti-(rabies virus strainera (evelyn-rockitniki-abelseth) glycoprotein ectodomain epitope g-iii), mus musculus monoclonal antibody · Immunoglobulin g2b, anti-(rabies virus strain evelyn-rockitniki-abelseth glycoprotein ectodomain epitope g-iii) (mus musculus monoclonal 62-71-3 .gamma.2b-chain), disulfide with mus musculus monoclonal 62-71-3 .kappa.-chain, dimer
- Code names
- 62-71-3
Resolves to
Compound
Which companies are running trials of Docaravimab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account